解码复杂的网络:肺瘤微环境中的细胞和分子相互作用
Bahjat Saeed Issa1, Ayat Hussein Adhab2, Morug Salih Mahdi3
1College of Pharmacy, Alnoor University, Nineveh, Iraq.
Journal of drug targeting
|December 21, 2024
概括
肺瘤微环境 (TME) 涉及复杂的细胞和分子相互作用,阻碍了抗瘤免疫力. 了解这些动态为肺癌治疗提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 肺瘤微环境 (TME) 是一个复杂的细胞和分子网络.
- 这种环境显著影响瘤的进展和治疗耐药性.
- 肺癌细胞及其流体可以抑制自然杀手 (NK) 细胞和T细胞的免疫反应.
研究的目的:
- 讨论肺 TME 中复杂的细胞和分子相互作用.
- 确定这些相互作用如何调节瘤进展和免疫逃避.
- 为肺癌的潜在治疗点提供见解.
主要方法:
- 关于肺TME组成和功能的当前文献的综述.
- 在TME中分析信号通路和分子介质.
- 讨论肺瘤使用的免疫逃避机制.
主要成果:
- 肺部TME包括多种细胞 (免疫,层状) 和分泌的因素 (生长因子,外体,表观遗传调节剂,细胞因子).
- 这些组成部分形成了一个复杂的网络,积极抑制抗瘤免疫反应.
- 瘤细胞和 stromal 元素协作促进瘤生长和抵抗.
结论:
- 了解肺TME相互作用对于开发有效的肺癌疗法至关重要.
- 针对TME的特定细胞和分子组成部分,可以克服治疗耐药性.
- 阐明这些多方面的相互作用可能会导致肺癌的新型治疗策略.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


